Emily Townsend is a partner in Goodwin’s Technology group in London. Emily advises clients on a broad range of matters throughout the corporate lifecycle, with a focus on venture capital and growth equity financings and M&A transactions.
Experience
- Dwelly on its $170 million Series B financing
- Flying Fish, Evantic, and BOND on their participation in the $1.1 billion investment round into Ineffable Intelligence
- Oxford Quantum Circuits on its $350 million Series C financing and $100 million Series B financing
- General Catalyst in the €150 million Series E financing of ICEYE
- The Chernin Group in its strategic partnership with Goalhanger
- General Catalyst, Bertelsmann, and Meridian Health Ventures on Phare Health’s acquisition by R1
- Omnipresent on its acquisition by Deel
- General Catalyst in the $67.5 million Series B financing of Lean Technologies
- Paid on its $21.6 million seed round
- Ravelin on its acquisition by Worldpay
- ETF Partners on its investment in the $75 million Series C financing of Riverlane
- Myricx on its £90 million Series A financing, co-led by Novo Holdings and Abingworth
- Relay Technologies on its $35 million and $10 million financings
- Anaphite on its £10.4 million funding round
- VavaCars on its $37 million Series C financing*
- Geopura on its £36 million Series A financing*
- Dawn Capital on its investment into Elwood Technologies as part of a $70 million Series A financing*
- Current Health on an acquisition by Best Buy for $400 million*
- Trustology on its sale to Bitpanda*
*Denotes experience prior to joining Goodwin
Areas of Practice
Credentials
Education
Legal Practice Course2016
BPP Law School
LLB2015
University of Leicester
Admissions
Bars
- England and Wales
